NDC 24208-535

ZIRGAN

Ganciclovir

ZIRGAN is a Ophthalmic Gel in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Ganciclovir.

Product ID24208-535_adf5012d-1077-42c8-ab9d-49ff64abf4a2
NDC24208-535
Product TypeHuman Prescription Drug
Proprietary NameZIRGAN
Generic NameGanciclovir
Dosage FormGel
Route of AdministrationOPHTHALMIC
Marketing Start Date2010-04-30
Marketing CategoryNDA / NDA
Application NumberNDA022211
Labeler NameBausch & Lomb Incorporated
Substance NameGANCICLOVIR
Active Ingredient Strength2 mg/g
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 24208-535-15

1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-15) > 1.5 g in 1 TUBE, WITH APPLICATOR
Marketing Start Date2010-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 24208-535-35 [24208053535]

ZIRGAN GEL
Marketing CategoryNDA
Application NumberNDA022211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2010-04-30

NDC 24208-535-32 [24208053532]

ZIRGAN GEL
Marketing CategoryNDA
Application NumberNDA022211
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-30
Marketing End Date2014-03-31

NDC 24208-535-15 [24208053515]

ZIRGAN GEL
Marketing CategoryNDA
Application NumberNDA022211
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-30

Drug Details

Active Ingredients

IngredientStrength
GANCICLOVIR1.5 mg/g

OpenFDA Data

SPL SET ID:ea25e7ac-7a93-4ec8-975b-2cec197e1c27
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 864650
  • 388052
  • Pharmacological Class

    • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • DNA Polymerase Inhibitors [MoA]
    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]
    • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • DNA Polymerase Inhibitors [MoA]
    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    Medicade Reported Pricing

    24208053535 ZIRGAN 0.15% OPHTHALMIC GEL

    Pricing Unit: GM | Drug Type:

    NDC Crossover Matching brand name "ZIRGAN" or generic name "Ganciclovir"

    NDCBrand NameGeneric Name
    24208-535ZIRGANganciclovir
    24201-500GanciclovirGanciclovir
    42023-173GanciclovirGanciclovir
    51754-2500GANCICLOVIRGANCICLOVIR
    63304-636GANCICLOVIRGANCICLOVIR
    63304-637GANCICLOVIRGANCICLOVIR

    Trademark Results [ZIRGAN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZIRGAN
    ZIRGAN
    77765422 3854668 Live/Registered
    LABORATOIRES THEA
    2009-06-22
    ZIRGAN
    ZIRGAN
    77369284 not registered Dead/Abandoned
    LABORATOIRES THEA SAS
    2008-01-11

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.